NCT02470637View on ClinicalTrials.gov

Single Dose Clamp Study to Evaluate Concentration-time Profile and Metabolic Activity of 3 Dose Levels of Afrezza and 3 Dose Levels of Insulin Lispro in Patients With Type 1 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG

SAR439065

"Pharmaceutical form:dry powder insulin~Route of administration: inhalation"

DRUG

Insulin lispro

"Pharmaceutical form:solution for injection~Route of administration: subcutaneous"

Trial Locations (1)

41460

Investigational Site Number 276001, Neuss

Sponsors
All Listed Sponsors
lead

Mannkind Corporation

INDUSTRY